# Scott H. Kaufmann

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/scott-h-kaufmann/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50,793 |
| Field | PARP inhibition in cancer therapy |
| h-index | 111 |
| i10-index | 377 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5054370710 |
| ORCID iD | https://orcid.org/0000-0002-4900-7145 |
| Works | 975 |

## Researcher papers

- [Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial](https://scholariq.org/papers/rucaparib-in-relapsed-platinum-sensitive-high-grade-ovarian-carcinoma-ariel2/)
- [<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma](https://scholariq.org/papers/i-brca-i-reversion-mutations-in-circulating-tumor-dna-predict-primary-and/)
- [Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial](https://scholariq.org/papers/olaparib-and-specific-pi3k-inhibitor-alpelisib-for-patients-with-epithelial/)
- [Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)](https://scholariq.org/papers/molecular-and-clinical-determinants-of-response-and-resistance-to-rucaparib-for/)
- [APOBEC3B Upregulation and Genomic Mutation Patterns in Serous Ovarian Carcinoma](https://scholariq.org/papers/apobec3b-upregulation-and-genomic-mutation-patterns-in-serous-ovarian-carcinoma/)

## Researcher topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cell death mechanisms and regulation](https://scholariq.org/topics/cell-death-mechanisms-and-regulation/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.